Takeda begins Phase III dengue vaccine trial
September 8, 2016Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial
Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …
Clinical Trial Transparency
September 8, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trial, clinical trial transparency, transparency
Amid the global political and economic turmoil taking place, one small pharma story got much less attention than it should …
FDA to review MSD’s Keytruda as a first-line lung cancer treatment
September 7, 2016Research and Development FDA, MSD, Merck, first-line, keytruda, lung cancer, non-small cell lung cancer, opdivo
The US Food and Drug Administration has accepted the supplemental biologics license application from MSD, known as Merck in the …
Pfizer appoints new chief scientific officer for neuroscience research
September 7, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Dr Ole Isacson has been named as the chief scientific officer at Pfizer’s neuroscience research unit. He will continue to …
Allergan CEO outlines ‘social contract with patients’
September 7, 2016Research and Development, Sales and Marketing Allergan, Brent Saunders, CEO, blog
Highlighting a recent shift in the priorities of the pharmaceutical industry, Allergan CEO and president Brent Saunders has outlined a …
Tonix tanks after Phase III failure
September 7, 2016Research and Development PTSD, fibromylagia, phase III failure, tonix, tonix pharmaceuticals
New York-based Tonix Pharmaceuticals has suffered an almost 60% fall in their share price, after the announcement that its fibromyalgia …
Allergan acquires biotech Retrosense for $60 million
September 7, 2016Research and Development, Sales and Marketing Allergan, Retrosense, acquisition
Allergan has announced that it has acquired Retrosense, a biotech focused on novel gene therapy approaches to restore vision in …
Antitrust investigation launched into Mylan and the EpiPen scandal
September 7, 2016Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal
The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …
European Commission approves new RA treatment from BMS
September 6, 2016Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, EMA, EU, Orencia, RA, abatacept, approval, rheumatoid arthritis
Bristol-Myers Squibb has received approval from the European Commission for rheumatoid arthritis (RA) treatment Orencia (abatacept), making it the first …
Bayer takes another shot at Monsanto acquisition
September 6, 2016Manufacturing and Production, Sales and Marketing Bayer, acqusition, monsanto
Bayer has made another move to acquire US-based Monsanto, raising the price it is prepared to pay in an effort …
Eisai “cannot understand” German agency’s recommendation to reject Halaven
September 6, 2016Manufacturing and Production, Research and Development Eisai, Germany, Halaven, IQWIG, german
Eisai has issued a statement to declare their “bewilderment” following a decision from the German Institute for Quality and Efficiency …
Taiho invests in Arcus Biosciences as part of $70 million deal
September 6, 2016Manufacturing and Production, Sales and Marketing Arcus, investment, taiho
Taiho Ventures has invested in California-based Arcus Biosciences alongside GV, Invus, DROIA Oncology Ventures and Stanford University as part of …
Horizon and Fulcrum Therapeutics form CRISPR collaboration
September 6, 2016Manufacturing and Production, Research and Development Horizon Discovery, crispr, fulcrum, fulcrum therapeutics, gene editing, horizon, rare diseases
Horizon Discovery has announced that it has entered into a partnership with Fulcrum Therapeutics to utilise Horizon’s CRISPR-based screening platform …
Non-invasive ventilation touted for COPD treatment at respiratory meeting
September 6, 2016Manufacturing and Production, Research and Development COPD, resmed
ResMed has presented results at the European Respiratory Society international congress, touting home non-invasive ventilation (NIV) as part of a …
Takeda secures $312 million zika vaccine development contract
September 5, 2016Manufacturing and Production, Research and Development, Sales and Marketing Takeda, US government, Zika, world health organization
Takeda has announced that it has been granted a $312 million contract from the US government to develop an inactivated, …
Clinton announces plan to tackle “unjustified price hikes”
September 5, 2016Sales and Marketing Drug pricing, Shkreli, US, clinton, generic drugs, president, price hikes
US Presidential candidate Hillary Clinton has outlined a wide-ranging set of proposals to tackle what she calls the “unjustified price …
GSK announce positive results for chronic obstructive pulmonary disease treatment
September 5, 2016Manufacturing and Production, Research and Development, Sales and Marketing GlaxoSmithKline, Innoviva, Revlar Ellipta, chronic obstructive pulmonary disease
GlaxoSmithKline and its partner Innoviva have announced that its Relvar Ellipta achieved positive results in its COPD Salford lung study …
MSD drops osteoporosis trial drug due to stroke risk
September 5, 2016Research and Development, Sales and Marketing MSD, Merck, Odanacatib, osteoporosis, stroke
MSD, known as Merck in the US and Canada, has announced that it has finally decided to discontinue the development …
AZ’s first respiratory biologic meets primary endpoints in Phase III trials
September 5, 2016Research and Development, Sales and Marketing AstraZeneca, asthma, benralizumab, biologic, respiratory, severe asthma
AstraZeneca has presented Phase III data at the European Respiratory Society (ERS) international congress which shows that trial biologic benralizumab …
Top ten stories in the pharmaceutical industry this week
September 2, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile.com, top ten
As Mylan is left reeling from the backlash on its EpiPen price increase in the US, many lost their jobs …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
